Betterware (BWMX) Q1 2026 Earnings Transcript

Betterware de México reported 0.3% revenue growth to MXN 8.6 billion, but EBITDA rose 14% and margin expanded to 17.4% from 15.3%, while net income nearly doubled and free cash flow conversion reached 58% of EBITDA. Management reiterated 4%-8% full-year revenue growth guidance, highlighted improving momentum in Betterware and Jafra US, and said the Tupperware deal should close in Q2 and be immediately earnings accretive, adding an estimated 40% to EPS. The quarter also featured stronger leverage and returns, with net debt/EBITDA down to 1.5x, ROTA at 22.7%, and ROIC at 27%.

Analysis

The core signal is not the modest top-line print; it is the operating leverage embedded in a business that has already de-risked the balance sheet and is now turning incremental demand into disproportionate earnings. When a company can hold revenue nearly flat, expand EBITDA margin, and still improve cash conversion, that usually marks the end of the “restructuring story” and the beginning of a compounding story. The market is likely underestimating how much of this is self-help rather than macro, which matters because self-help tends to persist even if consumer demand only improves mildly.

The biggest second-order beneficiary is the equity holder through capital allocation optionality. With leverage moving toward a sub-2x regime even after the deal, management has room to keep paying dividends while funding integration, which reduces the usual M&A overhang. If the transaction closes on schedule and the earnings accretion is even half of what management is signaling, the stock should rerate on both higher near-term EPS and lower perceived financing risk; if approval slips, the tape could temporarily punish it because the market is implicitly paying for the deal bridge today.

The contrarian miss is that the near-term weakness in one brand may actually be a feature, not a bug: management appears to be optimizing consultant productivity before re-accelerating headcount, which can create a cleaner growth curve later in the year. That said, this also makes the second quarter a critical inflection point—if recruitment does not reaccelerate, the market will conclude that the recovery is more fragile than management admits. Supply chain inflation from freight/oil is a real but manageable risk; the bigger downside is not margin compression, but a delay in proving that the growth algorithm still works after the productivity reset.

Key Decisions for Investors

• Long BWMX on any pullback over the next 1-3 weeks; thesis is 15-25% upside over 6-9 months if the Q2 inflection in associate growth and Tupperware approval both land, with downside capped by dividend support and low leverage.
• Buy BWMX common and fund it with a partial short in a higher-multiple direct-selling/consumer-discretionary name as a pair trade; the trade is to own self-help with cash return while shorting a name more exposed to macro beta and lower margin resilience.
• Add a dated event-driven call spread in BWMX into the Q2 regulatory window; risk/reward is attractive if approval arrives and the market reprices the Brazilian option, but premium paid should be limited because delay risk is binary.
• If already long, keep a tight stop only on a failed Q2 rebound in Jafra Mexico; that is the cleanest tell that management’s operational reset is not translating into top-line recovery.
• Monitor CRM as a secondary beneficiary only on the implementation milestone, not as a standalone trade; if Salesforce rollout drives visible productivity gains, it supports the BWMX thesis rather than just being a vendor win.